ClinConnect ClinConnect Logo
Search / Trial NCT06132334

The Effects of Upper Extremity Aerobic Exercise Training in Patients With Type 2 Diabetes

Launched by GAZI UNIVERSITY · Nov 13, 2023

Trial Information

Current as of November 10, 2025

Recruiting

Keywords

Type 2 Diabetes Mellitus Muscle Oxygen Oxygen Consumption Physical Activity

ClinConnect Summary

This clinical trial is investigating how aerobic exercise training for the upper body can help people with Type 2 diabetes manage their condition better. Regular physical activity is known to be important for controlling blood sugar levels and overall health. The study is currently looking for participants between the ages of 18 and 65 who have been diagnosed with Type 2 diabetes and are able to walk and follow instructions. However, people with certain health issues, like severe obesity, lung disease, or recent heart problems, will not be eligible to join.

Participants in this trial can expect to take part in upper body aerobic exercises designed to improve their fitness and potentially help with diabetes management. This study aims to understand how this type of exercise impacts the health of individuals with Type 2 diabetes. It's a great opportunity for those looking to engage in physical activity while contributing to important research in diabetes care.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Diagnosed with T2DM,
  • Aged between 18-65 years,
  • Able to walk and cooperate,
  • Patients who volunteer to participate in the study.
  • Exclusion Criteria:
  • Body mass index \>40 kg/m2,
  • A known lung disease,
  • Serious neurological, neuromuscular, orthopedic, or other diseases affecting physical functions,
  • Cognitive impairment that causes them to have difficulty understanding and following exercise test instructions,
  • Having had any cardiac event or surgery in the last six months,
  • Participated in a planned exercise program within the last three months,
  • Uncontrolled hypertension,
  • An acute pulmonary exacerbation within the last 4 weeks, have an acute upper or lower respiratory tract infection,
  • Presence of diabetes complications such as nephropathy, retinopathy and severe neuropathy,
  • Contraindications for exercise testing and/or exercise training according to the American College of Sports Medicine.

About Gazi University

Gazi University, a leading research institution based in Ankara, Turkey, is committed to advancing medical knowledge and improving patient care through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university integrates cutting-edge research with clinical practice to explore new therapeutic approaches and enhance existing treatments. Gazi University adheres to the highest ethical standards and regulatory guidelines, ensuring the integrity and safety of its clinical trials. By fostering partnerships with healthcare professionals and academic institutions, Gazi University aims to contribute significantly to the global scientific community and address pressing health challenges.

Locations

çankaya, Ankara, Turkey

Patients applied

0 patients applied

Trial Officials

Fidan YILMAZ, MSc

Study Chair

Gazi University

Ayşenur SARISAKALOĞLU, MSc

Principal Investigator

Gazi University

Serpil GÜLKAN, MD

Principal Investigator

Pursaklar State Hospital

Meral BOŞNAK GÜÇLÜ, Prof. Dr.

Study Director

Gazi University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported